Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Atherosclerosis III: Management01:26

Atherosclerosis III: Management

70
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
70
Rheumatic Heart Disease III: Medical Management01:21

Rheumatic Heart Disease III: Medical Management

65
Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
65
Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

32
Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
32
Endocarditis III: Medical Management01:18

Endocarditis III: Medical Management

51
Infective endocarditis management involves a multifaceted approach encompassing infection prevention, lifestyle modifications, pharmacological therapy, and surgical management.Infection Prevention:Hand Hygiene: Thorough handwashing is crucial to prevent the spread of infection. Hand hygiene should be performed regularly, especially before and after using the restroom.Oral Hygiene: Good oral hygiene is essential. It includes brushing teeth immediately after waking up and before bed, flossing...
51

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Cerebellar microRNA-206 tunes Purkinje neuron firing dynamics to control sensorimotor gating.

bioRxiv : the preprint server for biology·2026
Same author

Antiphospholipid antibodies in acute and post-treatment Lyme disease.

Infection and immunity·2026
Same author

Knowledge, attitudes, and concerns about medical cannabis among U.S. healthcare professionals.

Journal of cannabis research·2026
Same author

ChEA-KG and ChEA-KG-TS: a network-based transcription factor enrichment analysis tool with an accompanying time-series workflow.

Nucleic acids research·2026
Same author

Setting, context and the regulatory atmospheres of psychedelic medicine.

The International journal on drug policy·2026
Same author

A tool based on objective data to identify patients at elevated risk of hospital-onset <i>Staphylococcus aureus</i> bacteremia: a nested case-control study.

Antimicrobial stewardship & healthcare epidemiology : ASHE·2026

Related Experiment Video

Updated: Oct 21, 2025

Detecting the Lyme Disease Spirochete, Borrelia Burgdorferi, in Ticks Using Nested PCR
07:20

Detecting the Lyme Disease Spirochete, Borrelia Burgdorferi, in Ticks Using Nested PCR

Published on: February 4, 2018

18.3K

Recent Progress in Lyme Disease and Remaining Challenges.

Jason R Bobe1, Brandon L Jutras2, Elizabeth J Horn3

  • 1Icahn School of Medicine at Mount Sinai, New York, NY, United States.

Frontiers in Medicine
|September 6, 2021
PubMed
Summary

Lyme disease, a common tick-borne illness, often causes persistent symptoms post-treatment. Increased research funding is crucial for advancing understanding and developing better prevention, diagnosis, and treatment strategies for Lyme borreliosis.

Keywords:
Lyme diseasePTLDdiagnosisfield buildingpathogenesispreventiontreatmentvaccine

More Related Videos

Cultivation Methods of Spirochetes from Borrelia burgdorferi Sensu Lato Complex and Relapsing Fever Borrelia
10:37

Cultivation Methods of Spirochetes from Borrelia burgdorferi Sensu Lato Complex and Relapsing Fever Borrelia

Published on: November 25, 2022

6.0K
Author Spotlight: Controlled Human Exposure Model for Tick Research and Lyme Disease Studies
04:47

Author Spotlight: Controlled Human Exposure Model for Tick Research and Lyme Disease Studies

Published on: December 1, 2023

818

Related Experiment Videos

Last Updated: Oct 21, 2025

Detecting the Lyme Disease Spirochete, Borrelia Burgdorferi, in Ticks Using Nested PCR
07:20

Detecting the Lyme Disease Spirochete, Borrelia Burgdorferi, in Ticks Using Nested PCR

Published on: February 4, 2018

18.3K
Cultivation Methods of Spirochetes from Borrelia burgdorferi Sensu Lato Complex and Relapsing Fever Borrelia
10:37

Cultivation Methods of Spirochetes from Borrelia burgdorferi Sensu Lato Complex and Relapsing Fever Borrelia

Published on: November 25, 2022

6.0K
Author Spotlight: Controlled Human Exposure Model for Tick Research and Lyme Disease Studies
04:47

Author Spotlight: Controlled Human Exposure Model for Tick Research and Lyme Disease Studies

Published on: December 1, 2023

818

Area of Science:

  • Infectious Diseases
  • Epidemiology
  • Public Health

Background:

  • Lyme disease (Lyme borreliosis) is the most prevalent vector-borne disease in the U.S., affecting an estimated 476,000 individuals annually.
  • Historically, the long-term effects of Lyme disease have been debated, but evidence increasingly indicates persistent symptoms in many treated patients.
  • Significant underfunding hampers scientific and clinical progress in understanding, preventing, diagnosing, and treating Lyme disease.

Purpose of the Study:

  • To review recent advancements in Lyme and tick-borne disease research in the U.S. over the past five years.
  • To identify critical knowledge gaps and challenges in the diagnosis, clinical presentation, and treatment of Lyme disease.
  • To emphasize the urgent need for increased support for Lyme disease research.

Main Methods:

  • Literature review of scientific publications from the past five years.
  • Synthesis of current understanding of Lyme disease epidemiology and clinical manifestations.
  • Identification of research priorities and funding needs.

Main Results:

  • Growing evidence supports the existence of persistent symptoms following Lyme disease treatment.
  • Numerous questions remain regarding optimal diagnosis, clinical presentation, and treatment efficacy.
  • Underfunding has limited the development of innovative solutions for Lyme and other tick-borne diseases.

Conclusions:

  • There is a critical need for enhanced research funding to address the complexities of Lyme disease.
  • Further investigation into the molecular mechanisms of persistent Lyme disease is essential.
  • Progress in prevention, diagnosis, and treatment requires sustained scientific and clinical support.